论文部分内容阅读
肝素诱发的血小板减少症伴有血栓形成和/或出血,可威胁病人的生命和肢体,进而在医学法律上威胁着医生。本组50例肝素治疗诱发血小板减少症(平均血小板计数为48,000/立方毫米)并发血栓形成和出血,约占接受肝素治疗病例的0.6%。这些并发症发生于接受猪肠和牛肺肝素治疗的患者;和剂量、给药方法无关;和年龄、性别、种族和血型亦无关。此症常常出现在肝素
Heparin-induced thrombocytopenia, associated with thrombosis and / or bleeding, can threaten the life and limbs of patients, thereby threatening doctors in medical law. The group of 50 heparin-induced thrombocytopenia (average platelet count 48,000 / cubic mm) complicated by thrombosis and bleeding, accounting for about 0.6% of patients receiving heparin. These complications occur in patients receiving porcine intestinal and bovine heparin treatment; and dose and method of administration has nothing to do; and age, gender, race and blood type has nothing to do. This disease often appears in heparin